Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma

Methylation is closely involved in the development of various carcinomas. However, few datasets are available for small cell lung cancer (SCLC) due to the scarcity of fresh tumor samples. The aim of the present study is to clarify relationships between clinicopathological features and results of the comprehensive genome‐wide methylation profile of SCLC. We investigated the genome‐wide DNA methylation status of 28 tumor and 13 normal lung tissues, and gene expression profiling of 25 SCLC tissues. Following unsupervised hierarchical clustering and non‐negative matrix factorization, gene ontology analysis was performed. Clustering of SCLC led to the important identification of a CpG island methylator phenotype (CIMP) of the tumor, with a significantly poorer prognosis (P = 0.002). Multivariate analyses revealed that postoperative chemotherapy and non‐CIMP were significantly good prognostic factors. Ontology analyses suggested that the extrinsic apoptosis pathway was suppressed, including TNFRSF1A, TNFRSF10A and TRADD in CIMP tumors. Here we revealed that CIMP was an important prognostic factor for resected SCLC. Delineation of this phenotype may also be useful for the development of novel apoptosis‐related chemotherapeutic agents for treatment of the aggressive tumor.

[1]  Shaowei Zhang,et al.  甲基化在肺癌研究领域的相关进展 , 2017, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[2]  Y. Ishikawa,et al.  Relationship of tumor PD‐L1 (CD274) expression with lower mortality in lung high‐grade neuroendocrine tumor , 2017, Cancer medicine.

[3]  C. Rudin,et al.  Unravelling the biology of SCLC: implications for therapy , 2017, Nature Reviews Clinical Oncology.

[4]  Hiroshi I. Suzuki,et al.  YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer , 2016, Cancer science.

[5]  John T. Poirier,et al.  DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2 , 2015 .

[6]  S. Ishikawa,et al.  A subset of small cell lung cancer with low neuroendocrine expression and good prognosis: a comparison study of surgical and inoperable cases with biopsy. , 2014, Human pathology.

[7]  T Takahashi,et al.  The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells , 2013, Oncogene.

[8]  O. Surova,et al.  Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL. , 2011, Carcinogenesis.

[9]  Fang Fang,et al.  Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis , 2011, Science Translational Medicine.

[10]  Xiao Zhang,et al.  Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.

[11]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[12]  T. Cotter,et al.  Apoptosis and cancer: the genesis of a research field , 2009, Nature Reviews Cancer.

[13]  Bekim Sadikovic,et al.  Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling. , 2009, Human molecular genetics.

[14]  Jae Hyuk Lee,et al.  Lack of death receptor 4 (DR4) expression through gene promoter methylation in gastric carcinoma , 2009, Langenbeck's Archives of Surgery.

[15]  S. Ogino,et al.  LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer , 2008, International journal of cancer.

[16]  Gabriele Schackert,et al.  CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. , 2007, Carcinogenesis.

[17]  Carl Virtanen,et al.  Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorization , 2005, Oncogene.

[18]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[19]  P. M. Das,et al.  DNA methylation and cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Herman.  Epigenetics in lung cancer: focus on progression and early lesions. , 2004, Chest.

[21]  Pablo Tamayo,et al.  Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Carl Virtanen,et al.  Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles , 2004, The Lancet.

[23]  R. Stahel,et al.  Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation , 2003, Cell Death and Differentiation.

[24]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[25]  W. Earnshaw,et al.  Induction of apoptosis by cancer chemotherapy. , 2000, Experimental cell research.

[26]  H. Sebastian Seung,et al.  Learning the parts of objects by non-negative matrix factorization , 1999, Nature.

[27]  J. Issa,et al.  Aging, DNA methylation and cancer. , 1999, Critical reviews in oncology/hematology.

[28]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Hitoshi Nomura,et al.  ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis. , 2012, Lung cancer.

[30]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[31]  A. Ernst,et al.  Small Cell Carcinoma , 2010 .

[32]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[33]  E. Brambilla.  Small Cell Carcinoma , 2008 .

[34]  Hisao Asamura,et al.  Neuroendocrine neoplasms of the lung: a prognostic spectrum. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[36]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[37]  T. Hawley,et al.  The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. , 1994, Oncogene.